Summary InspireMD, Inc., (InspireMD) formerly Saguaro Resources, Inc. is a medical device company that offers technology products. The company develops and commercializes stent platform MGuard technology. Its MGuard is based on net that is wrapped with an expandable MicroNet. InspireMD uses MGuard technology develops products that are applied in interventional cardiology and other vascular procedures. The company offers MGuard Prime which include mesh sleeve wrapped around a cobalt-chromium stent. It utilizes its technology to make products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company sells its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Boston, Massachusetts, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company InspireMD, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 InspireMD, Inc. Company Snapshot 6 InspireMD, Inc. Company Overview 6 InspireMD, Inc. Pipeline Products and Clinical Trials Overview 7 InspireMD, Inc.- Pipeline Analysis Overview 9 Key Facts 9 InspireMD, Inc. - Major Products and Services 10 InspireMD, Inc. Pipeline Products by Development Stage 11 InspireMD, Inc. Clinical Trials by Trial Status 13 InspireMD, Inc. Pipeline Products Overview 14 CGuard Embolic Protection System 14 CGuard Embolic Protection System Product Overview 14 CGuard Embolic Protection System Clinical Trial 15 MGuard Drug Eluting Stent 16 MGuard Drug Eluting Stent Product Overview 16 MGuard Embolic Protection Stent 17 MGuard Embolic Protection Stent Product Overview 17 MGuard Prime EPS 18 MGuard Prime EPS Product Overview 18 NVGuard Neurovascular 19 NVGuard Neurovascular Product Overview 19 PVGuard Peripheral 20 PVGuard Peripheral Product Overview 20 RGuard Renal 21 RGuard Renal Product Overview 21 InspireMD, Inc. - Key Competitors 22 InspireMD, Inc. - Key Employees 23 InspireMD, Inc. - Locations And Subsidiaries 24 Head Office 24 Other Locations & Subsidiaries 24 Recent Developments 25 InspireMD, Inc., Recent Developments 25 May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016 25 May 05, 2016: InspireMD Announces Late-Breaking Trial Presentation on CGuard Embolic Prevention System at EuroPCR 2016 Conference 26 Mar 28, 2016: InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015 26 Jan 22, 2016: InspireMD Aligns Operations and Leadership Team, Appoints Isaac Blech as Vice Chairman of the Board 28 Dec 02, 2015: InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard Delivery Catheters 29 Nov 20, 2015: InspireMD Announces Positive Twelve Month Follow-Up CARENET Trial Data at VEITH Symposium 2015 30 Nov 10, 2015: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2015 30 Oct 19, 2015: InspireMD Announces CGuard Approval in Argentina 32 Oct 05, 2015: InspireMD Announces CGuard Approval in Columbia 33 Sep 28, 2015: InspireMD Announces Full Market Launch of CGuard Distributed by Penumbra at CIRSE Annual Congress 33 Appendix 35 Methodology 35 About GlobalData 35 Contact Us 35 Disclaimer 35
List of Tables
InspireMD, Inc. Pipeline Products and Clinical Trials Overview 7 InspireMD, Inc. Pipeline Products by Equipment Type 7 InspireMD, Inc. Pipeline Products by Indication 8 InspireMD, Inc. Clinical Trials by Trial Status 8 InspireMD, Inc., Key Facts 9 InspireMD, Inc., Major Products and Services 10 InspireMD, Inc. Number of Pipeline Products by Development Stage 11 InspireMD, Inc. Pipeline Products Summary by Development Stage 12 InspireMD, Inc. Clinical Trials by Trial Status 13 InspireMD, Inc. Clinical Trials Summary 13 CGuard Embolic Protection System - Product Status 14 CGuard Embolic Protection System - Product Description 14 CGuard Embolic Protection System - Prospective Evaluation of All-comer Percutaneous Carotid Revascularization In Symptomatic and Increased-risk Asymptomatic Carotid Artery Stenosis 15 MGuard Drug Eluting Stent - Product Status 16 MGuard Drug Eluting Stent - Product Description 16 MGuard Embolic Protection Stent - Product Status 17 MGuard Embolic Protection Stent - Product Description 17 MGuard Prime EPS - Product Status 18 MGuard Prime EPS - Product Description 18 NVGuard Neurovascular - Product Status 19 NVGuard Neurovascular - Product Description 19 PVGuard Peripheral - Product Status 20 PVGuard Peripheral - Product Description 20 RGuard Renal - Product Status 21 RGuard Renal - Product Description 21 InspireMD, Inc., Key Employees 23 InspireMD, Inc., Other Locations 24
List of Figures
InspireMD, Inc. Pipeline Products by Equipment Type 8 InspireMD, Inc. Pipeline Products by Development Stage 11 InspireMD, Inc. Clinical Trials by Trial Status 13
Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to driveRead More...
Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growiRead More...
Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceuticaRead More...
Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energRead More...
Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous industRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.